E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPOPIO0144(Opioid peptide)
DFBP ID DFBPOPIO0144
Peptide sequence YPFPGPIPN
Type Native peptide
Peptide/Function name Opioid peptide, [Pro67]-β-Casomorphin-9
Function-activity relationship
Main bioactivity Opioid activity
Otheir bioactivity ACE-inhibitory activity [D1], Antihypertensive activity [D2], DPP IV-inhibitory activity [D3], Multifunctional activity [D4]
Calculated physicochemical properties
Three-letter amino acid Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro-Asn
Single-letter amino acid YPFPGPIPN
Peptide length 9
Peptide mass
Experimental mass Theoretical mass
N.D 1001.14 Da c
Net charge 0.00 c
Isoelectric point (pI) 5.92 c
IC50 N.D
pIC50 N.D
GRAVY -0.4778 c
Hydrophilic residue ratio 77.78% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk protien
Precursor protein β-Casein
Residue position

f(60-68)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Opioid activity [Pro67]-β-Casomorphin-9 showed stronger opioid activity and was opioid μ-receptor ligands (Receptor affinity IC50 = 11 μM) with agonistic activities (Opioid activity in GPI assay IC50 = 4.3 μM). β-CMs of [His67]-type was more active than those of [Pro67]-type. As shown in table 1.
Table 1 Opioid activity of β-CMs
Peptides
Opioid activity in GPI assay IC50 (μM)
Receptor affinity IC50 (μM)
References
[His67]-β-Casomorphin-9
(YPFPGPIHN)
3.3
3.3

[Pro67]-β-Casomorphin-9
(YPFPGPIPN)
4.3
11
Opioid agonist
[1]
Specific target protein(s) Specific Target Protein(s):
Mu-type opioid receptor
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N1[C@@]([H])(CCC1)C(=O)NCC(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(=O)N)C(=O)O
Preparation method
Mode of preparation

Enzymatic hydrolysis

Enzyme(s)/starter culture

To simulate in vivo digestion, bovine β-casein was digested by pepsin, pancreatin (or chymotrypsin, or trypsin) and then by leucine aminopeptidase (LAP).

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

The sequence of bovine β-casein (59-81) is -LVYPFPGPI-Pro67/His67-NSLPQNIPPLTQTP-.

Database cross-references
DFBP
[D1] DFBPACEI0662, DFBPACEI1470
[D2] DFBPANHY0575
[D3] DFBPDPIV0072
[D4] DFBPMUFU0146
BIOPEP-UWM [D5] 7486
APD [D6] -
BioPepDB [D7] -
MBPDB [D8] -
Reference(s)
Primary literature Jinsmaa Y, Yoshikawa M. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein. Peptides. 1999;20(8):957-62.
PMID: 10503774
Other literature(s)

[1] Kostyra E, Sienkiewiczsz┅apka E, Jarmo┅owska B, et al. Opioid peptides derived from milk proteins.[J]. Polish Journal of Food & Nutrition Sciences, 2004.

PubDate 1999
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214